Ginkgo Bioworks Holdings, Inc. (DNA)

USD 7.04

(1.15%)

Long Term Debt Summary of Ginkgo Bioworks Holdings, Inc.

  • Ginkgo Bioworks Holdings, Inc.'s latest annual long term debt in 2023 was 221.83 Million USD , down -46.32% from previous year.
  • Ginkgo Bioworks Holdings, Inc.'s latest quarterly long term debt in 2024 Q2 was 452.26 Million USD , down 0.0% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported annual long term debt of 413.25 Million USD in 2022, up 1754.58% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported annual long term debt of 22.28 Million USD in 2021, up 34.9% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported quarterly long term debt of 234.49 Million USD for 2024 Q1, down 0.0% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported quarterly long term debt of 221.83 Million USD for 2023 FY, down -46.32% from previous quarter.

Annual Long Term Debt Chart of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Historical Annual Long Term Debt of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Year Long Term Debt Long Term Debt Growth
2023 221.83 Million USD -46.32%
2022 413.25 Million USD 1754.58%
2021 22.28 Million USD 34.9%
2020 16.51 Million USD -1.49%
2019 16.76 Million USD 0.0%
2001 413.25 Million USD 0.0%

Peer Long Term Debt Comparison of Ginkgo Bioworks Holdings, Inc.

Name Long Term Debt Long Term Debt Difference
ADC Therapeutics SA 112.73 Million USD -96.784%
Alto Neuroscience, Inc. 151.33 Million USD -46.582%
Annovis Bio, Inc. - USD -Infinity%
Biohaven Pharmaceutical Holding Company Ltd. 27.56 Million USD -704.654%
Nuvation Bio Inc. 2.03 Million USD -10800.983%
Nuvation Bio Inc. 2.03 Million USD -10800.983%
Arcus Biosciences, Inc. 110 Million USD -101.668%
Zymeworks Inc. 22.46 Million USD -887.645%